Carregant...
Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases
Cytokines are major drivers of autoimmunity, and biologic agents targeting cytokines have revolutionized the treatment of immune-mediated diseases. Despite the effectiveness of these drugs, they do not induce complete remission in all patients, prompting the development of alternative strategies—inc...
Guardat en:
| Publicat a: | Nat Rev Rheumatol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4688091/ https://ncbi.nlm.nih.gov/pubmed/26633291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrrheum.2015.167 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|